Literature DB >> 29307294

Mendelian randomization in multiple sclerosis: A causal role for vitamin D and obesity?

Adil Harroud1, J Brent Richards2.   

Abstract

The etiology of multiple sclerosis (MS) involves a complex interplay of genetic and environmental factors. Epidemiologic studies have furthered our understanding of these risk factors but remain limited by residual confounding and potential for reverse causation, particularly in MS where time of disease onset is not known. Mendelian randomization (MR) uses genetic variants to study the causal effect of modifiable exposures on an outcome. This method avoids some of the limitations of classical epidemiology and can strengthen causal inference. Here, we introduce the basic concepts of MR and review its contributions to the field of MS. Indeed, several studies using MR have now provided support for a causal role for low vitamin D level and obesity in the development of MS.

Entities:  

Keywords:  Mendelian randomization; Multiple sclerosis; genetic epidemiology; obesity; vitamin D

Mesh:

Substances:

Year:  2018        PMID: 29307294     DOI: 10.1177/1352458517737373

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  14 in total

1.  Shedding light on the link between early life sun exposure and risk of multiple sclerosis: results from the EnvIMS Study.

Authors:  Sandra Magalhaes; Maura Pugliatti; Trond Riise; Kjell-Morten Myhr; Antonio Ciampi; Kjetil Bjornevik; Christina Wolfson
Journal:  Int J Epidemiol       Date:  2019-08-01       Impact factor: 7.196

Review 2.  Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions.

Authors:  Roger Bouillon; Claudio Marcocci; Geert Carmeliet; Daniel Bikle; John H White; Bess Dawson-Hughes; Paul Lips; Craig F Munns; Marise Lazaretti-Castro; Andrea Giustina; John Bilezikian
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

3.  Mendelian randomization provides no evidence for a causal role in the bidirectional relationship between depression and multiple sclerosis.

Authors:  Adil Harroud; Ruth Ann Marrie; Kathryn C Fitzgerald; Amber Salter; Yi Lu; Mitulkumar Patel; Kaarina Kowalec
Journal:  Mult Scler       Date:  2021-02-16       Impact factor: 6.312

Review 4.  Vitamin D, Autoimmune Disease and Rheumatoid Arthritis.

Authors:  Stephanie R Harrison; Danyang Li; Louisa E Jeffery; Karim Raza; Martin Hewison
Journal:  Calcif Tissue Int       Date:  2019-07-08       Impact factor: 4.333

5.  CCN3 is dynamically regulated by treatment and disease state in multiple sclerosis.

Authors:  Michelle Naughton; Jill Moffat; George Eleftheriadis; Nira de la Vega Gallardo; Andrew Young; John Falconer; Kristen Hawkins; Ben Pearson; Bernard Perbal; Andrew Hogan; Paul Moynagh; Sam Loveless; Neil P Robertson; Bruno Gran; Rachael Kee; Stella Hughes; Gavin McDonnell; Owain Howell; Denise C Fitzgerald
Journal:  J Neuroinflammation       Date:  2020-11-22       Impact factor: 8.322

6.  Mendelian randomization study updates the effect of 25-hydroxyvitamin D levels on the risk of multiple sclerosis.

Authors:  Renxi Wang
Journal:  J Transl Med       Date:  2022-01-03       Impact factor: 5.531

7.  Sex Steroids and Osteoarthritis: A Mendelian Randomization Study.

Authors:  Yi-Shang Yan; Zihao Qu; Dan-Qing Yu; Wei Wang; Shigui Yan; He-Feng Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-23       Impact factor: 5.555

8.  A mendelian randomization study on causal effects of 25(OH)vitamin D levels on attention deficit/hyperactivity disorder.

Authors:  Lars Libuda; Roaa Naaresh; Christine Ludwig; Björn-Hergen Laabs; Jochen Antel; Manuel Föcker; Johannes Hebebrand; Anke Hinney; Triinu Peters
Journal:  Eur J Nutr       Date:  2020-11-27       Impact factor: 5.614

Review 9.  Age at Menarche and Risk of Multiple Sclerosis: Current Progress From Epidemiological Investigations.

Authors:  Xia Jiang; Tomas Olsson; Lars Alfredsson
Journal:  Front Immunol       Date:  2018-11-13       Impact factor: 7.561

10.  Serum Uric Acid Level and Multiple Sclerosis: A Mendelian Randomization Study.

Authors:  Peng-Peng Niu; Bo Song; Xue Wang; Yu-Ming Xu
Journal:  Front Genet       Date:  2020-03-30       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.